Atlas Trials

Prediction Value of the BreathID 13C-Methacetin Breath Test for Hepatic Decompensation

Clinical trial NCT02084160 · COMPLETED

Trial details

NCT number
NCT02084160
Sponsor
Meridian Bioscience, Inc.
Status
COMPLETED
Study type
OBSERVATIONAL
Chronic Liver Disease
Start date
2014-03-01
Primary completion
2018-10-01
Enrollment
579

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.